Your browser doesn't support javascript.
loading
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.
Sax, Paul E; Wohl, David; Yin, Michael T; Post, Frank; DeJesus, Edwin; Saag, Michael; Pozniak, Anton; Thompson, Melanie; Podzamczer, Daniel; Molina, Jean Michel; Oka, Shinichi; Koenig, Ellen; Trottier, Benoit; Andrade-Villanueva, Jaime; Crofoot, Gordon; Custodio, Joseph M; Plummer, Andrew; Zhong, Lijie; Cao, Huyen; Martin, Hal; Callebaut, Christian; Cheng, Andrew K; Fordyce, Marshall W; McCallister, Scott.
Afiliación
  • Sax PE; Division of Infectious Diseases and Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA. Electronic address: psax@partners.org.
  • Wohl D; Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
  • Yin MT; Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
  • Post F; Department of HIV Medicine, King's College, Hospital NHS Foundation Trust, London, UK.
  • DeJesus E; Orlando Immunology Center, Orlando, FL, USA.
  • Saag M; Department of Medicine, University of Alabama Birmingham, Birmingham, AL, USA.
  • Pozniak A; Department of Medicine, Chelsea and Westminster Hospital, NHS Foundation Trust, London, UK.
  • Thompson M; AIDS Research Consortium of Atlanta, Atlanta, GA, USA.
  • Podzamczer D; HIV Unit, Infectious Disease Service. Hospital Universitari de Bellvitge, Barcelona, Spain.
  • Molina JM; Hôpital Saint Louis, Paris, France.
  • Oka S; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Koenig E; Instituto Dominicano de Estudios Virologicos (IDEV), Santo Domingo, Dominican Republic.
  • Trottier B; Clinique Medicale L'Actuale in Montreal, Montreal, Canada.
  • Andrade-Villanueva J; Unidad de VIH del Hospital Civil de Guadalajara, CUCS, U de G Guadalajara, Mexico.
  • Crofoot G; Gordon Crofoot Research, Houston, TX, USA.
  • Custodio JM; Gilead Sciences, Foster City, CA, USA.
  • Plummer A; Gilead Sciences, Foster City, CA, USA.
  • Zhong L; Gilead Sciences, Foster City, CA, USA.
  • Cao H; Gilead Sciences, Foster City, CA, USA.
  • Martin H; Gilead Sciences, Foster City, CA, USA.
  • Callebaut C; Gilead Sciences, Foster City, CA, USA.
  • Cheng AK; Gilead Sciences, Foster City, CA, USA.
  • Fordyce MW; Gilead Sciences, Foster City, CA, USA.
  • McCallister S; Gilead Sciences, Foster City, CA, USA.
Lancet ; 385(9987): 2606-15, 2015 Jun 27.
Article en En | MEDLINE | ID: mdl-25890673

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiazoles / Carbamatos / Adenina / Infecciones por VIH / Quinolonas / Fármacos Anti-VIH / Desoxicitidina / Organofosfonatos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Año: 2015 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiazoles / Carbamatos / Adenina / Infecciones por VIH / Quinolonas / Fármacos Anti-VIH / Desoxicitidina / Organofosfonatos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Año: 2015 Tipo del documento: Article Pais de publicación: Reino Unido